You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Anti-angiogenesis agent

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Melanoma, Malignant Melanoma, Stage IIIA Melanoma Trial in Orange (procedure, other, drug)

Completed
Has Results
  • Melanoma
  • +4 more
  • therapeutic conventional surgery
  • +3 more
  • Orange, California
    Chao Family Comprehensive Cancer Center
Dec 30, 2020

Breast Cancer, Angiogenesis Trial in Burlington (Aspirin)

Completed
  • Breast Cancer
  • Angiogenesis
  • Burlington, Vermont
    University of Vermont
Sep 15, 2020

Angiogenesis Inhibitor Plus Anti-PD-1/PD-L1 Antibody in Advanced

Recruiting
  • Esophageal Neoplasms
  • an anti-PD-1/PD-L1 antibody plus an angiogenesis inhibitor
  • Zhengzhou, Henan, China
    The First Affiliated Hospital of Zhengzhou University
Apr 21, 2022

Anti-angiogenesis Combined With PD-1/PD-L1 Therapy in Advanced

Not yet recruiting
  • Carcinoma, Hepatocellular
    • (no location specified)
    May 16, 2022

    Solid Tumor, Adult, Solid Tumor, Gastric Cancer Trial in Seongnam, Seoul (PB101)

    Recruiting
    • Solid Tumor, Adult
    • +5 more
    • Seongnam, Korea, Republic of
    • +2 more
    Oct 11, 2023

    Nephrotoxicity Trial (Huaier Granule, VEGFR-TKIs)

    Not yet recruiting
    • Nephrotoxicity
    • (no location specified)
    Jan 5, 2023

    Thyroidectomy, Goiter, Thyroid Cancer Trial in Taipei (Oxidized regenerated cellulose(ORC), Hyaluronic acid(HA))

    Recruiting
    • Thyroidectomy
    • +2 more
    • Oxidized regenerated cellulose(ORC)
    • Hyaluronic acid(HA)
    • Taipei, Taiwan
      National Taiwan University Hospital
    May 1, 2023

    NSCLC Trial in Tianjin (Tislelizumab, Pemetrexed, Bevacizumab)

    Not yet recruiting
    • Non-Small Cell Lung Cancer
    • Tianjin, Tianjin, China
      Tianjin Medical University Cancer Institute and Hospital
    Jul 11, 2022

    Lumbar Disc Disease, Epidural Fibrosis, Failed Back Surgery Syndrome Trial in Pathum Wan (Mediclore, Normal Saline)

    Not yet recruiting
    • Lumbar Disc Disease
    • +2 more
    • Pathum Wan, Bangkok, Thailand
      King Chulalongkorn Memorial Hospital
    Sep 12, 2023

    Non-small-cell Lung Cancer Trial in Shanghai (gefitinib combined with chemo, gefitinib combined with apatinib, gefitinib single

    Unknown status
    • Non-small-cell Lung Cancer
    • gefitinib combined with chemotherapy
    • +2 more
    • Shanghai, Shanghai, China
      Shanghai Pulmonary Hospital;
    Jul 31, 2020

    Esophagus Cancer, Bladder Cancer, Liver Cancer Trial (Intravenous injection of P-IL-2, P-IL-2 plus Anti-PD-1 Monoclonal

    Not yet recruiting
    • Esophagus Cancer
    • +4 more
    • Intravenous injection of P-IL-2
    • P-IL-2 plus Anti-PD-1 Monoclonal Antibody
    • (no location specified)
    Apr 24, 2023

    Adhesion Trial in New Taipei City (Use 4DryField)

    Recruiting
    • Adhesion
    • Use 4DryField
    • New Taipei City, Taiwan
      Taipei Medical University Shuang-Ho Hospital
    Oct 12, 2022

    Advanced Solid Tumors Trial in Canada, United States (LCB84, Anti-PD-1 mAb)

    Not yet recruiting
    • Advanced Solid Tumors
    • LCB84
    • Anti-PD-1 monoclonal antibody
    • Los Angeles, California
    • +6 more
    Jul 4, 2023

    Salivary Gland Cancer Trial (vedicitumomab (Edisil, RC48), vedicitumomab in combination with pyrrolizidine, RC48 in combination

    Not yet recruiting
    • Salivary Gland Cancer
    • vedicitumomab (Edisil, RC48）
    • +3 more
    • (no location specified)
    Jun 9, 2023

    Solid Tumor Trial in Chuo-ku (ROSE12, Atezolizumab)

    Recruiting
    • Solid Tumor
    • Chuo-ku, Tokyo, Japan
      National Cancer Center Hospital
    Jun 14, 2023

    Advanced Solid Tumor Trial in Kuching (BL0020)

    Not yet recruiting
    • Advanced Solid Tumor
    • Kuching, Malaysia
      Sarawak General Hospital
    May 24, 2023

    Renal Cell Carcinoma, Melanoma, Non Small Cell Lung Cancer Trial (HFB200603, Tislelizumab)

    Not yet recruiting
    • Renal Cell Carcinoma
    • +4 more
    • (no location specified)
    Mar 15, 2023

    Ulcerative Colitis Trial in Al Minya (Saffron, Placebo)

    Not yet recruiting
    • Ulcerative Colitis
    • Al Minyā, Minia, Egypt
      Minia University
    Feb 3, 2023

    Metastatic Castration Resistant Prostate Cancer Trial in London (IMU-935)

    Recruiting
    • Metastatic Castration Resistant Prostate Cancer
    • London, United Kingdom
      Institute of Cancer Research
    Jan 31, 2023

    Overweight and Obesity, Hypercholesterolemia, Hypertriglyceridemia Trial in Murcia (Silibinin A)

    Active, not recruiting
    • Overweight and Obesity
    • +2 more
    • Silibinin A
    • Murcia, Spain
      Faculty of Nursing. Catholic University of Murcia
    May 17, 2022

    Overweight and Obesity Trial in Lahore (Phaseolus Vulgaris, Placebo)

    Not yet recruiting
    • Overweight and Obesity
    • Phaseolus Vulgaris
    • Placebo
    • Lahore, Punjab, Pakistan
    • +1 more
    Jul 6, 2022

    Oral-facial Pain Trial in Catania (Palmitoyletinolamide, Placebo)

    Recruiting
    • Oral-facial Pain
    • Palmitoyletinolamide
    • Placebo
    • Catania, Italy
      AOU Policlinico G. Rodolico
    May 23, 2023

    PRP, Losartan, Muscle Injury Trial (Autologous platelets rich plasma, Autologous platelets rich plasma + oral LOSARTAN

    Completed
    • PRP
    • +3 more
    • Autologous platelets rich plasma
    • Autologous platelets rich plasma + oral LOSARTAN administration
    • (no location specified)
    Apr 12, 2023

    Therapeutic Combination in Advanced or Metastatic Kidney Cancer

    Not yet recruiting
    • Renal Cell Carcinoma
    • +2 more
    • Blood collection
    • Tumour samples
    • Paris, France
    • +1 more
    Mar 9, 2022

    Metastatic Cancer, Unresectable Malignant Tumor Trial in Groningen (Anti-CD8 PET imaging agent)

    Recruiting
    • Metastatic Cancer
    • Unresectable Malignant Neoplasm
    • Anti-CD8 PET imaging agent
    • Groningen, Netherlands
      University Medical Center Groningen
    Mar 1, 2022